Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complicated Skin and Structure Infection”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Testing effectiveness (Phase 2)Study completedNCT00671580
What this trial is testing

Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and Skin Structure Infection

Who this might be right for
Skin Infections
Protez Pharmaceuticals, Inc. 99
Testing effectiveness (Phase 2)Study completedNCT00426933
What this trial is testing

Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections

Who this might be right for
Soft Tissue Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 100
Testing effectiveness (Phase 2)Study completedNCT00303589
What this trial is testing

Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Who this might be right for
Soft Tissue Infections
Hoffmann-La Roche 313
Large-scale testing (Phase 3)Study completedNCT00228982
What this trial is testing

Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

Who this might be right for
Skin Diseases, InfectiousSkin Diseases, BacterialStaphylococcal Skin Infections
Basilea Pharmaceutica 784
Testing effectiveness (Phase 2)Study completedNCT00077675
What this trial is testing

Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)

Who this might be right for
Infections, Gram-positive Bacterial
Cumberland Pharmaceuticals 201
Post-approval studies (Phase 4)Study completedNCT00368537
What this trial is testing

Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections

Who this might be right for
Skin Diseases, Bacterial
Wyeth is now a wholly owned subsidiary of Pfizer 550
Post-approval studies (Phase 4)Study completedNCT00711802
What this trial is testing

Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections

Who this might be right for
Skin Diseases, Infectious
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 396
Large-scale testing (Phase 3)Study completedNCT00091819
What this trial is testing

Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus

Who this might be right for
Staphylococcal Skin Infection
Cumberland Pharmaceuticals 862
Large-scale testing (Phase 3)WithdrawnNCT00911573
What this trial is testing

Study Evaluating Tigecycline Versus Clindamycin Or Vancomycin On Complicated Skin And Skin Structure Infections Including Those Due To Methicillin-Resistant Staphylococcus Aureus (MRSA) In Pediatric Subjects

Who this might be right for
Skin DiseasesInfection
Wyeth is now a wholly owned subsidiary of Pfizer
Large-scale testing (Phase 3)Study completedNCT00228410
What this trial is testing

Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections

Who this might be right for
Skin Diseases, Infectious
Wyeth is now a wholly owned subsidiary of Pfizer 503
Testing effectiveness (Phase 2)Study completedNCT01593761
What this trial is testing

Phase 2a Study of CG400549 for the Treatment of cABSSSI Caused by Methicillin-resistant Staphylococcus Aureus

Who this might be right for
Skin Infection
CrystalGenomics, Inc. 20
Large-scale testing (Phase 3)Study completedNCT01400867
What this trial is testing

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections

Who this might be right for
Infections, Pediatrics
Forest Laboratories 163
Not applicableStudy completedNCT01072539
What this trial is testing

Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment

Who this might be right for
Complicated Skin and Skin Structure InfectionsComplicated Intra-abdominal InfectionsCommunity-Acquired Bacterial Pneumonia
Pfizer 3,172
Large-scale testing (Phase 3)Study completedNCT00828971
What this trial is testing

Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs

Who this might be right for
Infectious Diseases
Bayer 16
Large-scale testing (Phase 3)Ended earlyNCT01199783
What this trial is testing

Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment

Who this might be right for
Diabetic Foot
Ruhr University of Bochum 1
Not applicableStudy completedNCT01363271
What this trial is testing

Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients

Who this might be right for
Complicated Skin and Structure InfectionNosocomial Pneumonia
Pfizer 7,260
Not applicableStudy completedNCT00997997
What this trial is testing

Avelox in Complicated Skin and Skin Structure Infections

Who this might be right for
Skin Diseases, Bacterial
Bayer 6,127
Large-scale testing (Phase 3)WithdrawnNCT00876850
What this trial is testing

Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

Who this might be right for
Skin Structures and Soft Tissue Infections
Paratek Pharmaceuticals Inc
Post-approval studies (Phase 4)Study completedNCT01549613
What this trial is testing

Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections

Who this might be right for
CellulitisSkin Infections
University of Cincinnati 104
Testing effectiveness (Phase 2)Study completedNCT00061633
What this trial is testing

Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)

Who this might be right for
Infections, Gram-Positive BacterialAbscessBurns+3 more
Cumberland Pharmaceuticals 169
Next Page